43 Paul Tudor Jones II MerckInc Trades
Paul Tudor Jones II acquired 625 Thousand MerckInc shares worth $48 Million. That's 0.43% of their equity portfolio (37th largest holding). The first MerckInc trade was made in Q2 2013. Since then Paul Tudor Jones II bought shares 38 more times and sold shares on 29 occasions. The investor's estimated purchase price is $59.6 Million, resulting in a loss of 19%.
News about Merck & Co Inc and Paul Tudor Jones II
Final Trade: DAL, MRK, GS, HII
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Merck Ends Keytruda Combo Melanoma Study Due to Futility
Merck (NYSE: MRK ) announced that it is discontinuing a cohort of the phase III study evaluating a co-formulation of its blockbuster PD-L1 inhibitor, Keytrud...
FDA approves Merck''s Keytruda for FIGO 2014 cervical cancer
Merck (MRK) said the FDA has approved Keytruda in combination with chemoradiotherapy for the treatment of FIGO 2014 Stage III-IVA cervical cancer. Read more ...
Merck Highlights Robust Oncology, Hematology Pipeline With Four Agents in Phase III Trials
… lymphocytic lymphoma, non-small cell lung cancer , endometrial carcinoma, and metastatic castration … lymphoma (SLL); non-small cell lung cancer (NSCLC); c...